Tags

Type your tag names separated by a space and hit enter

Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome.
J Pharmacokinet Pharmacodyn. 2020 06; 47(3):187-188.JP

Authors+Show Affiliations

GlaxoSmithKline, Collegeville, PA, USA. malek.x.okour@gsk.com.College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.GlaxoSmithKline, London, UK.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32405664

Citation

Okour, Malek, et al. "Hydroxychloroquine and Azithromycin as Potential Treatments for COVID-19; Clinical Status Impacts the Outcome." Journal of Pharmacokinetics and Pharmacodynamics, vol. 47, no. 3, 2020, pp. 187-188.
Okour M, Al-Kofahi M, Austin D. Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome. J Pharmacokinet Pharmacodyn. 2020;47(3):187-188.
Okour, M., Al-Kofahi, M., & Austin, D. (2020). Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome. Journal of Pharmacokinetics and Pharmacodynamics, 47(3), 187-188. https://doi.org/10.1007/s10928-020-09689-x
Okour M, Al-Kofahi M, Austin D. Hydroxychloroquine and Azithromycin as Potential Treatments for COVID-19; Clinical Status Impacts the Outcome. J Pharmacokinet Pharmacodyn. 2020;47(3):187-188. PubMed PMID: 32405664.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome. AU - Okour,Malek, AU - Al-Kofahi,Mahmoud, AU - Austin,Daren, Y1 - 2020/05/13/ PY - 2020/04/27/received PY - 2020/05/04/accepted PY - 2020/5/15/pubmed PY - 2020/7/1/medline PY - 2020/5/15/entrez SP - 187 EP - 188 JF - Journal of pharmacokinetics and pharmacodynamics JO - J Pharmacokinet Pharmacodyn VL - 47 IS - 3 SN - 1573-8744 UR - https://www.unboundmedicine.com/medline/citation/32405664/Hydroxychloroquine_and_azithromycin_as_potential_treatments_for_COVID_19 L2 - https://doi.org/10.1007/s10928-020-09689-x DB - PRIME DP - Unbound Medicine ER -